RadNet Stock Price and Value Analysis

RadNet (NasdaqGM:RDNT) in our automated value investing analysis, with the cash flow history and price comparison below.

Key Facts

Advertisement helps keep Trendshare free for most readers.

Hold-time calculator

Estimate how long you need to hold RadNet to reach your target.

Target type

RDNT Free Cash Flow Trend

Free Cash Flow trendline for RDNT
Free Cash Flow trendline for RadNet
CSV

Based on historical returns, we believe that RadNet can grow its free cash at a rate of about 31%. That's positive!

AdvantagesDisadvantagesNeutral
  • This stock is available at a great discount!
  • This company is making money at a great rate!
  • This company is solid.
  • This company has wild ups and downs.
  • This company pays no dividend.

Inside the RDNT Numbers

RDNT Price
(RadNet stock price per share)
$76.97
[?] PE Ratio versus Sector 62% higher than other Healthcare stocks
[?] PE Ratio versus Industry 78% lower than other Diagnostics & Research stocks
[?] Cash Yield 1.27%
[?] Free Cash Flow Jitter 42%

Insider Activity Summary

In the six months to 2026-11-13, no insider bought shares, and 3 insiders sold in 4 trades, about $3.0 million.

The six months before that had 0 buys and 11 sales.

Recent Insider Activity

Open-market buys and sells reported by RadNet's officers, directors, and 10% owners on SEC Form 4. Routine transactions (tax withholding, option exercises, and stock grants) are excluded -- these are discretionary trades only.

Date Insider Type Shares Price
2026-06-18 SWARTZ DAVID L Sell 2,699 $53.89
2026-06-16 Wesdorp Cornelis (Pres & CEO, Digital Health) Sell 4,750 $58.11
2026-06-15 Forthuber Stephen M (Pres & CEO-Eastern Operations) Sell 24,214 $57.79
2026-06-15 Forthuber Stephen M (Pres & CEO-Eastern Operations) Sell 19,853 $58.61
2026-03-19 Sorensen Alma Gregory (Chief Strategy Officer) Sell 5,346 $62.82
2026-03-19 Sorensen Alma Gregory (Chief Strategy Officer) Sell 100 $63.59
2026-03-19 Sorensen Alma Gregory (Chief Strategy Officer) Sell 9,554 $61.84
2026-03-18 Sorensen Alma Gregory (Chief Strategy Officer) Sell 800 $62.72
2026-03-18 Sorensen Alma Gregory (Chief Strategy Officer) Sell 14,200 $62.12
2025-12-05 Forthuber Stephen M (Pres & COO-Eastern Operations) Sell 31,790 $77.99

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 8,878,163 shares shorted. With 65,833,753 shares available for purchase and an average trading volume over the past 10 trading days of 1,008,820, it would take at least 8.8 days for all of the short holders to cover their shorts.

Related guides: good annual rate of return · high-yield stocks · forecasting earnings growth

Free Cash Flow by Fiscal Year

Each year names the SEC filer that reported it, so a change of filer shows up here.

Fiscal yearSEC filer (CIK)Free cash flow (USD millions)
2009 790526 70.5
2010 790526 15.2
2011 790526 54.7
2012 790526 72.3
2013 790526 63.3
2014 790526 8.7
2015 790526 44.4
2016 790526 68.2
2017 790526 113.9
2018 790526 75.2
2019 790526 59.2
2020 790526 206.8
2021 790526 123.9
2022 790526 126.3
2023 790526 215.4
2024 790526 233.0
2025 790526 298.8

Download the yearly data as CSV.

Price Versus Our Estimated Value

Every one of the 17 fiscal years we have for RadNet under its current filer shows positive free cash flow.

At $76.97, RadNet trades below our safe value estimate of $77.71 and our fair value estimate of $119.56.

RadNet's average free cash flow rose sharply, from $46.8 million in its earliest three years to $249.1 million in its latest three.

Free cash flow is volatile from year to year, with a variability measure of 42%.

We do not have a dividend yield for RadNet.

Before you act on any of this, read what a margin of safety means and check the company's own filings.

Compared With Its Sector and Industry

Its trailing P/E ratio is 62% above the average for stocks in the Healthcare sector.

Its trailing P/E ratio is 78% below the average for stocks in the Diagnostics & Research industry.

A P/E ratio depends on trailing earnings, which one-time items can distort, so a lower P/E is not by itself evidence of value.

SEC Filer History

Every fiscal year on this page is reported by one SEC filer, CIK 790526.

Each figure on this page comes from that filer.

Risks to This Analysis

  • Free cash flow is volatile from year to year, so the estimates depend heavily on which years are included.
  • These figures are automated calculations from SEC filings and the recent price. They may contain errors, and they do not reflect lawsuits, management changes, or other events the filings do not show.

Advertisement supports free stock analysis content.

Questions to Answer Before You Invest in RDNT

Does RadNet have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

Worked example: RDNT

This example shows how we apply the Trendshare checklist to RDNT: earnings power, cash generation, valuation, and margin of safety.

We check: business quality, free cash flow, P/E, and margin of safety.

  1. Step 1 — Snapshot

    • Price: 76.97
    • Market cap: $6.1B
    • EPS: -0.29
  2. Step 2 — Valuation checks

    • P/E: —
    • FCF yield: 1.3%
    • Date checked: Nov 12, 2026
  3. Step 3 — Margin of safety

    • Compare price to fair value and safety price.
    • Look for durable cash generation and reasonable leverage.
    • Decide if it passes your personal checklist.